| abstract |
The invention provides compounds of formula (I) and their pharmaceutically acceptable salts: where L, X, R, R, R, R and R are as defined herein, methods for their preparation, pharmaceutical compositions containing them and their use in therapy, in particular in treatment or prevention of conditions associated with the orexin receptor subtype 1. |